Proximagen announces positive efficacy results in NIH epilepsy studies
Compulsory Acquisition of Outstanding Minster Shares
Offer for Minster declared unconditional
Strategic Update
Recommended Cash Offer for Minster Pharmaceuticals Plc
Completion of Acquisition of Cambridge Biotechnology Ltd
Proximagen Acquires Cambridge Biotechnology Ltd
Proximagen 2009 Interim Results
Proximagen Raises £50M

2003-2010 copyright Proximagen Neuroscience plc. All rights reserved.